Literature DB >> 6272986

Relationship between biological responsiveness to phorbol esters and receptor levels in GH4C1 rat pituitary cells.

S Jaken, A H Tashjian, P M Blumberg.   

Abstract

During a 24-hr incubation of GH4C1 cells with phorbol esters or thyrotropin-releasing hormone, there is a decrease in the number of phorbol esters receptors (down-modulation). The purpose of this study was to investigate whether this decrease in receptor number attenuated cellular responsiveness to subsequent challenge with phorbol esters. Accordingly, cellular sensitivity to a phorbol ester-mediated biological response, namely the decrease in binding of epidermal growth factor, was compared in control and down-modulated cells. This phorbol ester-mediated event is closely associated with phorbol ester receptor occupancy, and it is therefore an effect for which altered dose-response characteristics correlating with alterations in the number of phorbol ester receptors could be anticipated. In fact, during a 48-hr exposure to phorbol esters, GH4C1 cells become refractory to the effect on epidermal growth factor binding. This time course is similar to that for the loss of phorbol ester receptors. However, when cells are down modulated by pretreatment with phorbol ester or thyrotropin-releasing hormone and then (re)challenged with phorbol ester, no differences in dose-response characteristics were observed between control and down-modulated cells. We therefore conclude that phorbol ester receptor down-modulation does not affect cellular responsiveness to phorbol esters, at least when decreased epidermal growth factor binding is used as the marker for the phorbol ester-mediated event.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272986

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Effects of vinorelbine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitro.

Authors:  H Depenbrock; A Shirvani; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

2.  Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation.

Authors:  H Yamasaki; N Martel; A Fusco; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

3.  Differences in phorbol-ester-induced down-regulation of protein kinase C between cell lines.

Authors:  J C Adams; W J Gullick
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

4.  Two phorbol ester receptor affinities in partially transformed human urothelial cells and decrease of receptor binding in desensitized cells.

Authors:  B Christensen; J Skouv; J Kieler; H Autrup
Journal:  Experientia       Date:  1993-01-15

5.  Purification to homogeneity of protein kinase C from bovine brain--identity with the phorbol ester receptor.

Authors:  P J Parker; S Stabel; M D Waterfield
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.